Candesartan vs Pembrolizumab

## Candesartan vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Candesartan** and **Pembrolizumab**.

## Mechanism of Action

**Candesartan**: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Candesartan — 9 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Candesartan — C33H34N6O6; Pembrolizumab — N/A.

**Molecular Weight**: Candesartan — 610.6640 g/mol; Pembrolizumab — N/A.

**Type**: Candesartan — Small molecule; Pembrolizumab — Antibody.